CIRRHOSIS DUE TO HEPATITIS C
Clinical trials for CIRRHOSIS DUE TO HEPATITIS C explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS DUE TO HEPATITIS C trials appear
Sign up with your email to follow new studies for CIRRHOSIS DUE TO HEPATITIS C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol drug slow liver scarring?
Disease control Recruiting nowThis study tests whether rosuvastatin, a cholesterol-lowering drug, can safely slow or stop liver scarring (cirrhosis) compared to a placebo. About 256 adults with compensated cirrhosis will take the drug or placebo for 2 years. The main goal is to measure changes in liver stiffn…
Matched conditions: CIRRHOSIS DUE TO HEPATITIS C
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New MRI scan could spot liver cancer earlier in High-Risk patients
Diagnosis Recruiting nowThis study tests whether a 20-minute MRI scan without dye can detect liver cancer earlier than the usual ultrasound in 300 people with cirrhosis who are at high risk. Participants will get both scans every 6 months for 30 months. The goal is to see if the MRI catches cancers that…
Matched conditions: CIRRHOSIS DUE TO HEPATITIS C
Sponsor: University of Oxford • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC